Login / Signup

Heterobivalent Ligand for the Adenosine A 2A -Dopamine D 2 Receptor Heteromer.

Daniel PulidoVerònica Casadó-AngueraMarc Gómez-AutetNatàlia LlopartEstefanía MorenoNil Casajuana-MartinSergi FerréLeonardo PardoVicent CasadóMiriam Royo
Published in: Journal of medicinal chemistry (2022)
A G protein-coupled receptor heteromer that fulfills the established criteria for its existence in vivo is the complex between adenosine A 2A (A 2A R) and dopamine D 2 (D 2 R) receptors. Here, we have designed and synthesized heterobivalent ligands for the A 2A R-D 2 R heteromer with various spacer lengths. The indispensable simultaneous binding of these ligands to the two different orthosteric sites of the heteromer has been evaluated by radioligand competition-binding assays in the absence and presence of specific peptides that disrupt the formation of the heteromer, label-free dynamic mass redistribution assays in living cells, and molecular dynamic simulations. This combination of techniques has permitted us to identify compound 26 [ K DB1 (A 2A R) = 2.1 nM, K DB1 (D 2 R) = 0.13 nM], with a spacer length of 43-atoms, as a true bivalent ligand that simultaneously binds to the two different orthosteric sites. Moreover, bioluminescence resonance energy transfer experiments indicate that 26 favors the stabilization of the A 2A R-D 2 R heteromer.
Keyphrases
  • energy transfer
  • living cells
  • label free
  • fluorescent probe
  • quantum dots
  • high throughput
  • photodynamic therapy
  • single molecule
  • binding protein
  • molecular dynamics
  • dna binding